Magazine article from our research archive:

Prevacid approved in new formulation

TAP Pharmaceutical has received FDA clearance to market a new delayed-- release oral suspension form of its proton pump inhibitor, Prevacid (lansoprazole). The new formulation will be available in reconstitutable 15-mg and 30-mg unit-dose ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!